Gsk (GSK) Profit After Tax (2009 - 2026)

Gsk's Profit After Tax history runs 18 years deep, the most recent figure standing at $208.0 million for Q2 2026.

• In Q2 2026, Profit After Tax fell 92.67% year-over-year to $208.0 million; the TTM figure through Jun 2026 stood at $11.0 billion (up 33.54% YoY), while the FY2025 annual figure was $8.3 billion, up 119.82% from the prior year.
• Profit After Tax for Q2 2026 stood at $208.0 million, down from $2.5 billion in the prior quarter.
• The five-year high for Profit After Tax was $4.5 billion in Q4 2025, with the low at $81.9 million in Q3 2024.
• The 5-year median for Profit After Tax is $2.3 billion (2022), against an average of $2.3 billion.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax sank 95.79% in 2024, then jumped 4462.94% in 2025.
• Gsk's Profit After Tax stood at $3.0 billion in 2022, then jumped by 41.93% to $4.2 billion in 2023, then dropped by 26.94% to $3.1 billion in 2024, then jumped by 48.52% to $4.5 billion in 2025, then tumbled by 95.43% to $208.0 million in 2026.
• Business Quant data shows GSK's Profit After Tax at $208.0 million in Q2 2026, $2.5 billion in Q1 2026, and $4.5 billion in Q4 2025.